首页> 外文期刊>Journal of biomolecular techniques :JBT. >Advanced Imaging Approaches in Drug Discovery: Exploring Macromolecular Biodistribution to Brain Targets
【24h】

Advanced Imaging Approaches in Drug Discovery: Exploring Macromolecular Biodistribution to Brain Targets

机译:药物发现的先进成像方法:探索大分子生物分布到脑目标

获取原文
           

摘要

One of the greatest challenges to developing effective therapeutics targeting neurological disease lies in clearly understanding drug biodistribution and delivery mechanisms. The blood-brain barrier is a highly organized and nearly impermeable border made up of tightly packed endothelial cells that line the blood vessels and separate circulating blood from the brain's tissues and extracellular fluid in the central nervous system (CNS). A potential strategy for the delivery of large molecule therapeutics to the brain via systemic administration relies upon brain endothelial cell receptor-targeted approaches that allow for crossing the blood-brain barrier. Advanced imaging techniques are employed in order to evaluate the efficacy of such approaches. Using super resolution scanning laser microscopy, we are able to assess the cell-type specificity and subcellular distribution of both the receptor targets and the transport vehicle itself in the brain in vivo and thus better understand the kinetics of target engagement. To evaluate the larger scale biodistribution of potential therapeutics, we employ light sheet microscopy for whole brain imaging in cleared samples. Ongoing efforts are focused on improving both the throughput and reproducibility of these approaches in order to integrate image-based screening for drug delivery and target engagement into the neurodegenerative drug development workflow.
机译:开发靶向神经疾病有效治疗的最大挑战之一是明确了解药物生物分布和递送机制。血脑屏障是一种高度有组织的,几乎不可渗透的边界,由紧密包装的内皮细胞组成,该细胞与中枢神经系统(CNS)中的脑组织和细胞外液体分离出来的血管和单独的循环血液(CNS)。通过全身给药将大型分子治疗患者递送大型分子治疗剂的潜在策略依赖于脑内皮细胞受体靶向方法,其允许穿过血脑屏障。采用先进的成像技术来评估这些方法的功效。使用超分辨率扫描激光显微镜,我们能够评估受体靶标的细胞型特异性和亚细胞分布和在体内大脑中的运输车辆本身,从而更好地了解目标接合的动力学。为了评估潜在治疗剂的较大规模的生物分布,我们采用光薄片显微镜检查清除样品中的全脑成像。正在进行的努力,专注于改善这些方法的吞吐量和再现性,以将基于图像的筛查集成为药物递送和目标参与,并进入神经变性药物开发工作流程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号